Understanding and treating alcohol dependence (Q44917574)

7 December 2017

Understanding and treating alcohol dependence (English)

1 reference

7 December 2017

3

Marc A Schuckit

1 reference

7 December 2017

2

George F Koob

1 reference

7 December 2017

Bankole A Johnson

1

1 reference

7 December 2017

Barbara J Mason

series ordinal

4

1 reference

7 December 2017

Nassima Ait-Daoud

series ordinal

5

1 reference

7 December 2017

language of work or name

1 reference

1 March 2006

1 reference

Alcoholism: Clinical and Experimental Research

7 December 2017

1 reference

7 December 2017

30

1 reference

7 December 2017

3

1 reference

7 December 2017

567-584

1 reference

Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study

7 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Rapid suppression of alcohol withdrawal syndrome by baclofen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Neuropeptide Y distribution in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Alteration of ethanol self-administration by naltrexone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Comparison of the effects of drugs on hyperexcitability induced in hippocampal slices by withdrawal from chronic ethanol consumption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Serotonin 5-HT3 antagonists fail to affect ethanol self-administration of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Treatment of alcohol withdrawal with gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

The use of divalproex in alcohol relapse prevention: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Limbic activation during cue-induced cocaine craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Dramatic decreases in brain reward function during nicotine withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Pharmacological treatment of alcohol dependence: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Mechanism of the antialcohol effect of gamma-hydroxybutyric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Alcohol Problems in Adoptees Raised Apart From Alcoholic Biological Parents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

The endophenotype concept in psychiatry: etymology and strategic intentions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Mechanisms of action of valproate: a commentatory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Ondansetron reduces the craving of biologically predisposed alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Gabapentin treatment for insomnia associated with alcohol dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Alcohol self-administration, craving and HPA-axis activity: an intriguing relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Drug abuse: hedonic homeostatic dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Drug addiction, dysregulation of reward, and allostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Drug dependence: stress and dysregulation of brain reward pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Advances in development of medications for alcoholism treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Reinstatement of drug-seeking behavior produced by heroin-predictive environmental stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Serotonin3 receptor antagonism of alcohol intake: effects of drinking conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Gabapentin in the management of convulsive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Linkage disequilibrium between the beta frequency of the human EEG and a GABAA receptor gene locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Excessive ethanol drinking following a history of dependence: animal model of allostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Clinical pharmacokinetics of acamprosate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Oral ethanol self-administration in the rat: effect of naloxone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Testing the level of response to alcohol: social information processing model of alcoholism risk--a 20-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Autosomal linkage analysis for the level of response to alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

The importance of a compound stimulus in conditioned drug-seeking behavior following one week of extinction from self-administered cocaine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Effects of chronic ethanol exposure on neurophysiological responses to corticotropin-releasing factor and neuropeptide Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Common genetic risk factors for conduct disorder and alcohol dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Drug therapy for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

A three-pathway psychobiological model of craving for alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

The novel anticonvulsant, gabapentin, protects against both convulsant and anxiogenic aspects of the ethanol withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Neurobiology of craving, conditioned reward and relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

The search for genes related to a low-level response to alcohol determined by alcohol challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

Disturbances of hypothalamic-pituitary-adrenal axis functioning during ethanol withdrawal in six men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2005.00066.X

10.1111/J.1530-0277.2005.00066.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference